Page last updated: 2024-08-17

levodopa and Hyperactivity, Motor

levodopa has been researched along with Hyperactivity, Motor in 59 studies

Research

Studies (59)

Timeframe	Studies, this research(%)	All Research%
pre-1990	24 (40.68)	18.7374
1990's	9 (15.25)	18.2507
2000's	14 (23.73)	29.6817
2010's	10 (16.95)	24.3611
2020's	2 (3.39)	2.80

Authors

Authors	Studies
Cenci, MA; Espa, E; Grigoriou, S; Jakobsson, A; Odin, P; Timpka, J; von Grothusen, G	1
Kuo, CC; Pan, MK; Tai, CH; Tseng, SH; Wang, TR	1
Li, L; Sagot, B; Zhou, FM	1
Begemann, M; Damen, R; Elbracht, M; Häusler, M; Knopp, C; Kurth, I; Mull, M; Müller, B; Stoppe, A	1
Di Vico, IA; Novelli, A; Ramat, S; Sorbi, S; Terenzi, F	1
Antkiewicz-Michaluk, L; Kajta, M; Michaluk, J; Romańska, I; Wąsik, A	1
Antkiewicz-Michaluk, L; Michaluk, J; Romańska, I; Wąsik, A	1
Bingefors, K; Isacson, D; Kristiansen, IS; Nyholm, D	1
Buck, K; Ferger, B; Nicholas, AP	1
Garabadu, D; Joshi, VK; Krishnamurthy, S; Muruganandam, AV; Singh, GK	1
Asmus, F; Doherty, E; Gasser, T; King, MD; Langseth, A; Lynch, T; Munz, M; Nestor, T	1
Furuse, M; Hamasu, K; Kabuki, Y; Shigemi, K	1
Cohen, H; Pourcher, E; Rémillard, S	1
Brotchie, JM; Fox, SH; Gomez-Ramirez, J; Huot, P; Johnston, T; Reyes, G; Visanji, N	1
Marconi, S; Stocchi, F	1
Alachkar, A; Brotchie, JM; Jones, OT	1
Inoue, T; Koyama, M; Ogata, A; Tani, Y	1
Langston, JW; Protell, PH; Tan, LC; Togasaki, DM	1
Brotchie, JM; Crossman, AR; Mora, F; Segovia, G	1
Bernardini, S; Bonuccelli, U; Dell'Agnello, G; Gambaccini, G; Lucetti, C; Petrozzi, L; Rossi, G	1
Collier, TJ; Danielson, PD; Kurlan, R; Sladek, JR; Steece-Collier, K; Yurek, DM	1
Driguès, N; Sagi, Y; Youdim, MB	1
Brotchie, JM; Millan, MJ; Visanji, NP	1
Nicholas, AP	1
Vieregge, P	1
Yung, CY	1
Mejer Nielsen, B	1
Colucci d'Amato, C; De Angelis, G; Giordano, L; Iaccarino, C; Marmo, E; Mastrosimone, F	1
Hirayama, K; Yamada, T	1
Liu, DK	1
Hirato, M; Horikoshi, S; Kawashima, Y; Ohye, C; Satake, K; Shibazaki, T	1
Duchek, M; Ekberg, R; Fehling, C; Johansson, F; Johnels, B; Lindvall, B; Nordin, G; Olsson, JE; Sidén, A; Steg, G	1
Fünfgeld, EW	1
Arai, N; Isaji, M; Kojima, M; Kuno, S; Mizuta, E	1
Hagell, P; Widner, H	1
Maj, J; Rogóz, Z; Skuza, G	1
Kameda, K; Koyama, T; Kusumi, I; Miura, J; Suzuki, K; Tanaka, T	1
Wieck, HH	1
Aarskog, D; Fevang, FO; Klove, H; Stoa, KF; Thorsen, T	1
Del Pesce, M; Di Bella, P; Forastieri, L; Paggi, A; Quattrini, A	1
Fischer, PA; Jacobi, P; Schneider, E	1
Goetz, CG; Klawans, HL	1
Klawans, HL; Nausieda, PA; Weiner, WJ	1
Gerlach, J	1
Chase, TN; Glaubiger, GA; Shoulson, I	1
Hanzal, F	1
Gross, MD	1
Vladyka, V	1
Presthus, J	1
Costall, B; Naylor, RJ	1
Markova, ED	1
Arnold, G; Fritsch, K; Gasser, T; Oertel, W	1
Backlund, EO; Ebendal, T; Freedman, R; Hamberger, B; Hansson, P; Hoffer, B; Lindblom, U; Meyerson, B; Olson, L; Strömberg, I	1
Malyshev, IuI	1
Ackermann, H; Oertel, WH; Ziegler, W	1
Fahn, S	1
Kevlishvili, DA; Kvitsaridze, DA; Shubladze, LN	1
Bondarenko, ES; Malyshev, IuI	1
Il'inskiĭ, IA; Safronov, VA; Vasin, NIa	1

Reviews

5 review(s) available for levodopa and Hyperactivity, Motor

Article	Year
Factors associated with motor fluctuations and dyskinesia in Parkinson Disease: potential role of a new melevodopa plus carbidopa formulation (Sirio). Clinical neuropharmacology, 2010, Volume: 33, Issue:4 Topics: Antiparkinson Agents; Biological Availability; Carbidopa; Delayed-Action Preparations; Dopamine Agonists; Drug Combinations; Dyskinesia, Drug-Induced; Dyskinesias; Female; Humans; Hyperkinesis; Levodopa; Male; Parkinson Disease; Solubility; Time Factors	2010
[Idiopathic Parkinson's disease]. Fortschritte der Neurologie-Psychiatrie, 2008, Volume: 76, Issue:2 Topics: Antiparkinson Agents; Deep Brain Stimulation; Humans; Hyperkinesis; Levodopa; Mental Disorders; Parkinson Disease; Physical Therapy Modalities	2008
A review of clinical trials of lithium in neurology. Pharmacology, biochemistry, and behavior, 1984, Volume: 21 Suppl 1 Topics: Clinical Trials as Topic; Cluster Headache; Dyskinesia, Drug-Induced; Epilepsy; Headache; Humans; Huntington Disease; Hyperkinesis; Levodopa; Lithium; Meniere Disease; Migraine Disorders; Movement Disorders; Nervous System Diseases; Neurocognitive Disorders; Parkinson Disease; Sleep Wake Disorders; Torticollis	1984
[Dyskinesia (author's transl)]. No to shinkei = Brain and nerve, 1980, Volume: 32, Issue:11 Topics: Basal Ganglia Diseases; Dyskinesia, Drug-Induced; Humans; Hyperkinesis; Hypersensitivity, Delayed; Levodopa; Movement Disorders; Psychotropic Drugs	1980
Drug treatment of hyperkinetic movement disorders. Seminars in neurology, 1987, Volume: 7, Issue:2 Topics: Benzodiazepines; Botulinum Toxins; Dopamine; Dyskinesia, Drug-Induced; Humans; Hyperkinesis; Levodopa; Movement Disorders; Parasympathomimetics	1987

Trials

11 trial(s) available for levodopa and Hyperactivity, Motor

Article	Year
Fluctuating functions related to quality of life in advanced Parkinson disease: effects of duodenal levodopa infusion. Acta neurologica Scandinavica, 2008, Volume: 118, Issue:6 Topics: Aged; Antiparkinson Agents; Cross-Over Studies; Depressive Disorder; Disease Progression; Duodenum; Female; Gait Disorders, Neurologic; Humans; Hyperkinesis; Levodopa; Longitudinal Studies; Male; Middle Aged; Motor Activity; Movement Disorders; Parkinson Disease; Patient Satisfaction; Quality of Life; Sickness Impact Profile; Surveys and Questionnaires; Treatment Outcome	2008
Affect in Parkinson's disease: validation of the two-factor approach. Journal of the neurological sciences, 2010, Feb-15, Volume: 289, Issue:1-2 Topics: Aged; Antidepressive Agents; Antiparkinson Agents; Depression; Dopamine; Female; Humans; Hyperkinesis; Hypokinesia; Levodopa; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Psychiatric Status Rating Scales; Reproducibility of Results; Serotonin; Time Factors	2010
Amantadine in Huntington's disease: open-label video-blinded study. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2002, Volume: 23 Suppl 2 Topics: Aged; Amantadine; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Female; Humans; Huntington Disease; Hyperkinesis; Levodopa; Male; Receptors, N-Methyl-D-Aspartate; Time Factors	2002
A review of clinical trials of lithium in neurology. Pharmacology, biochemistry, and behavior, 1984, Volume: 21 Suppl 1 Topics: Clinical Trials as Topic; Cluster Headache; Dyskinesia, Drug-Induced; Epilepsy; Headache; Humans; Huntington Disease; Hyperkinesis; Levodopa; Lithium; Meniere Disease; Migraine Disorders; Movement Disorders; Nervous System Diseases; Neurocognitive Disorders; Parkinson Disease; Sleep Wake Disorders; Torticollis	1984
Tiapride in levodopa-induced involuntary movements. Acta neurologica Scandinavica, 1983, Volume: 67, Issue:6 Topics: Aged; Benzamides; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Hyperkinesis; Levodopa; Male; Middle Aged; Parkinson Disease; Random Allocation; Tiapamil Hydrochloride	1983
[L-dopa and bromocriptine in Parkinson disease. Early combination therapy has better effect]. Lakartidningen, 1993, Apr-21, Volume: 90, Issue:16 Topics: Bromocriptine; Drug Therapy, Combination; Dystonia; Female; Humans; Hyperkinesis; Levodopa; Male; Motor Activity; Parkinson Disease; Time Factors	1993
Computerised brain electrical activity findings of parkinson patients suffering from hyperkinetic side effects (hypersensitive dopamine syndrome) and a review of possible sources. Journal of neural transmission. Supplementum, 1995, Volume: 46 Topics: Aged; Aged, 80 and over; Analysis of Variance; Dopamine Agonists; Electroencephalography; Humans; Hyperkinesis; Levodopa; Middle Aged; Nootropic Agents; Parkinson Disease; Signal Processing, Computer-Assisted; Treatment Outcome	1995
The effect of the stimulant drugs, dextroamphetamine and methylphenidate, on secretion of growth hormone in hyperactive children. The Journal of pediatrics, 1977, Volume: 90, Issue:1 Topics: Adolescent; Child; Clinical Trials as Topic; Dextroamphetamine; Female; Growth Hormone; Homeostasis; Humans; Hyperkinesis; Levodopa; Male; Methylphenidate	1977
[Efficacy and side-effects of long term L-dopa therapy in Parkinsonian syndromes (evaluated by CT scan as well) (author's transl)]. Rivista di patologia nervosa e mentale, 1979, Volume: 99, Issue:5 Topics: Adult; Benserazide; Brain; Carbidopa; Clinical Trials as Topic; Confusion; Electrocardiography; Electroencephalography; Female; Humans; Hydrazines; Hyperkinesis; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary; Stomach Diseases; Tomography, X-Ray Computed	1979
Effect of CB 154 (2-bromo-alpha-ergocryptine) on paralysis agitans compared with Madopar in a double-blind, cross-over trial. Acta neurologica Scandinavica, 1976, Volume: 53, Issue:3 Topics: Aged; Azides; Benserazide; Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Combinations; Ergolines; Female; Humans; Hydrazines; Hyperkinesis; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Psychoses, Substance-Induced	1976
[Treatment of Parkinson's syndrome with L-dopa and L-carbidopa (author's transl)]. MMW, Munchener medizinische Wochenschrift, 1976, May-14, Volume: 118, Issue:20 Topics: Adult; Aged; Carbidopa; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hydrazines; Hyperkinesis; Levodopa; Male; Middle Aged; Parkinson Disease; Pyridoxine	1976

Other Studies

44 other study(ies) available for levodopa and Hyperactivity, Motor

Article	Year
Comparison of dyskinesia profiles after L-DOPA dose challenges with or without dopamine agonist coadministration. Neuropharmacology, 2023, 10-01, Volume: 237 Topics: Antiparkinson Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Dystonia; Humans; Hyperkinesis; Levodopa; Oxidopamine; Parkinson Disease	2023
Hyperpolarization of the subthalamic nucleus alleviates hyperkinetic movement disorders. Scientific reports, 2020, 05-19, Volume: 10, Issue:1 Topics: Animals; Cell Polarity; Deep Brain Stimulation; Disease Models, Animal; Humans; Hyperkinesis; Levodopa; Male; Nitro Compounds; Propionates; Rats; Subthalamic Nucleus; Treatment Outcome	2020
Hyperactive Response of Direct Pathway Striatal Projection Neurons to L-dopa and D1 Agonism in Freely Moving Parkinsonian Mice. Frontiers in neural circuits, 2018, Volume: 12 Topics: Animals; Behavior, Animal; Denervation; Disease Models, Animal; Dopamine Agonists; Dopaminergic Neurons; Homeodomain Proteins; Hyperkinesis; Levodopa; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neostriatum; Neurons; Parkinson Disease; Receptors, Dopamine D1; Substantia Nigra; Transcription Factors	2018
PDE10A mutation in two sisters with a hyperkinetic movement disorder - Response to levodopa. Parkinsonism & related disorders, 2019, Volume: 63 Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Child; Consanguinity; Dopamine Agents; Drug Combinations; Epilepsy, Temporal Lobe; Exome Sequencing; Female; Humans; Hyperkinesis; Infant; Levodopa; Movement Disorders; Phosphoric Diester Hydrolases; Siblings	2019
Dyskinesia-Hyperpyrexia Syndrome in Parkinson's disease with Deep Brain Stimulation and high-dose levodopa/carbidopa and entacapone. Parkinsonism & related disorders, 2019, Volume: 64 Topics: Antiparkinson Agents; Carbidopa; Catechols; Combined Modality Therapy; Deep Brain Stimulation; Drug Combinations; Drug Therapy, Combination; Fever; Humans; Hyperkinesis; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease	2019
1-Benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous neurotoxic compound, disturbs the behavioral and biochemical effects of L-DOPA: in vivo and ex vivo studies in the rat. Neurotoxicity research, 2014, Volume: 26, Issue:3 Topics: Animals; Corpus Striatum; Dopamine; Hippocampus; Hyperkinesis; In Vitro Techniques; Levodopa; Male; Neurotoxins; Parkinson Disease; Rats; Rats, Wistar; Serotonin; Substantia Nigra; Tetrahydroisoquinolines	2014
Chronic salsolinol administration prevents the behavioral and neurochemical effects of L-DOPA in rats. Neurotoxicity research, 2015, Volume: 27, Issue:4 Topics: Animals; Brain; Dopamine; Dopamine Agents; Hyperkinesis; Isoquinolines; Levodopa; Male; Motor Activity; Rats; Rats, Wistar	2015
Effects of levodopa on striatal monoamines in mice with levodopa-induced hyperactivity. Neuroscience letters, 2008, Oct-10, Volume: 443, Issue:3 Topics: Analysis of Variance; Animals; Antiparkinson Agents; Biogenic Monoamines; Chromatography, High Pressure Liquid; Corpus Striatum; Disease Models, Animal; Electrochemistry; Hyperkinesis; Levodopa; Mice; Mice, Inbred C57BL; MPTP Poisoning; Olfactory Bulb	2008
Antidepressant activity of Asparagus racemosus in rodent models. Pharmacology, biochemistry, and behavior, 2009, Volume: 91, Issue:3 Topics: 5-Hydroxytryptophan; Adrenergic alpha-Agonists; Aggression; Animals; Antidepressive Agents; Antioxidants; Asparagus Plant; Clonidine; Dopamine Agents; Dose-Response Relationship, Drug; Female; Head Movements; Helplessness, Learned; Hippocampus; Hyperkinesis; Levodopa; Lipid Peroxidation; Male; Medicine, Ayurvedic; Mice; Neostriatum; Plant Extracts; Plant Roots; Rats; Superoxide Dismutase; Swimming	2009
"Jerky" dystonia in children: spectrum of phenotypes and genetic testing. Movement disorders : official journal of the Movement Disorder Society, 2009, Apr-15, Volume: 24, Issue:5 Topics: Adolescent; Adult; Age of Onset; Anticonvulsants; Antiparkinson Agents; Child; Child, Preschool; DNA Mutational Analysis; Dystonia; Exons; Female; Genetic Testing; Genotype; Humans; Hyperkinesis; Levodopa; Longitudinal Studies; Male; Middle Aged; Muscle, Skeletal; Mutation; Myoclonus; Nuclear Proteins; Phenotype; Sarcoglycans; Severity of Illness Index; Thyroid Nuclear Factor 1; Transcription Factors; Tyrosine; Young Adult	2009
L-DOPA attenuates hyperactivity of Roborovskii hamsters. Behavioural pharmacology, 2009, Volume: 20, Issue:3 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Brain; Cricetinae; Dopamine; Dopamine Agents; Hyperkinesis; Levodopa; Male; Motor Activity; Neurotransmitter Agents; Norepinephrine; Serotonin	2009
Neuropsychiatric behaviors in the MPTP marmoset model of Parkinson's disease. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2010, Volume: 37, Issue:1 Topics: Animals; Antiparkinson Agents; Behavioral Symptoms; Callithrix; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Hyperkinesis; Levodopa; Parkinsonian Disorders; Reproducibility of Results	2010
Locomotor response to L-DOPA in reserpine-treated rats following central inhibition of aromatic L-amino acid decarboxylase: further evidence for non-dopaminergic actions of L-DOPA and its metabolites. Neuroscience research, 2010, Volume: 68, Issue:1 Topics: Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Aromatic-L-Amino-Acid Decarboxylases; Benserazide; Brain Chemistry; Disease Models, Animal; Dopamine Agents; Drug Combinations; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Hydrazines; Hyperkinesis; Levodopa; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Reserpine; Serotonin Receptor Agonists	2010
Effects of piclozotan (SUN N4057), a partial serotonin 1A receptor agonist, on motor complications induced by repeated administration of levodopa in parkinsonian rats. European journal of pharmacology, 2010, Dec-15, Volume: 649, Issue:1-3 Topics: Animals; Antiparkinson Agents; Behavior, Animal; Benserazide; Corpus Striatum; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Drug Partial Agonism; Dyskinesia, Drug-Induced; Hyperkinesis; Levodopa; Male; Microdialysis; Motor Activity; Oxazepines; Parkinson Disease; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Serotonin 5-HT1 Receptor Agonists	2010
The hyperkinetic abnormal movements scale: a tool for measuring levodopa-induced abnormal movements in squirrel monkeys. Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:5 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Female; Hyperkinesis; Levodopa; Male; Observer Variation; Random Allocation; Reproducibility of Results; Saimiri; Sensitivity and Specificity; Striatonigral Degeneration; Surveys and Questionnaires	2002
Effects of CB1 cannabinoid receptor modulating compounds on the hyperkinesia induced by high-dose levodopa in the reserpine-treated rat model of Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2003, Volume: 18, Issue:2 Topics: Adrenergic Uptake Inhibitors; Animals; Antiparkinson Agents; Behavior, Animal; Cannabinoid Receptor Modulators; Disease Models, Animal; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Hyperkinesis; Levodopa; Male; Parkinson Disease; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Reserpine; Time Factors	2003
Embryonic mesencephalic grafts increase levodopa-induced forelimb hyperkinesia in parkinsonian rats. Movement disorders : official journal of the Movement Disorder Society, 2003, Volume: 18, Issue:12 Topics: Animals; Antiparkinson Agents; Disease Models, Animal; Dopamine; Forelimb; Hyperkinesis; Levodopa; Male; Mesencephalon; Neurons; Parkinson Disease; Postoperative Complications; Rats; Rats, Inbred F344	2003
The neurochemical and behavioral effects of the novel cholinesterase-monoamine oxidase inhibitor, ladostigil, in response to L-dopa and L-tryptophan, in rats. British journal of pharmacology, 2005, Volume: 146, Issue:4 Topics: Animals; Basal Ganglia; Behavior, Animal; Carbamates; Cholinesterase Inhibitors; Dopamine; Hippocampus; Hyperkinesis; Indans; Levodopa; Lewy Body Disease; Male; Monoamine Oxidase Inhibitors; Motor Activity; Muscarinic Antagonists; Norepinephrine; Phenylcarbamates; Rats; Rats, Sprague-Dawley; Rivastigmine; Scopolamine; Serotonin; Time Factors; Tranylcypromine; Tryptophan	2005
Actions at sites other than D(3) receptors mediate the effects of BP897 on l-DOPA-induced hyperactivity in monoamine-depleted rats. Experimental neurology, 2006, Volume: 202, Issue:1 Topics: Adrenergic Uptake Inhibitors; Animals; Behavior, Animal; Biogenic Monoamines; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Hyperkinesis; Indoles; Levodopa; Male; Motor Activity; Piperazines; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D3; Reserpine; Time Factors	2006
Levodopa-induced hyperactivity in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Movement disorders : official journal of the Movement Disorder Society, 2007, Volume: 22, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Age Factors; Animals; Disease Models, Animal; Dopamine Agents; Hyperkinesis; Levodopa; Male; Mice; Mice, Inbred C57BL; Movement; Time Factors	2007
Personal experience with a combination of drugs in subjects with dopa resistant Parkinson's disease. Journal of medicine, 1980, Volume: 11, Issue:5-6 Topics: Amantadine; Amitriptyline; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Humans; Hyperkinesis; Levodopa; Lithium; Middle Aged; Parkinson Disease; Trazodone	1980
[Madopar in the treatment of paralysis agitans. I. Therapeutic efficacy and side-effects in 56 cases (author's transl)]. Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry, 1980, Volume: 13, Issue:3 Topics: Adult; Benserazide; Electrocardiography; Female; Humans; Hydrazines; Hyperkinesis; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease	1980
Different cerebral metabolism between parkinsonian rigidity and hyperkinesia (DID, chorea, dystonia). A PET study. Advances in neurology, 1993, Volume: 60 Topics: Basal Ganglia; Blood Glucose; Brain Mapping; Cerebral Cortex; Chorea; Dominance, Cerebral; Dystonia; Energy Metabolism; Humans; Hyperkinesis; Levodopa; Muscle Rigidity; Neural Pathways; Oxygen Consumption; Parkinson Disease; Thalamic Nuclei; Tomography, Emission-Computed	1993
Combined effects of cabergoline and L-dopa on parkinsonism in MPTP-treated cynomolgus monkeys. Journal of neural transmission (Vienna, Austria : 1996), 1996, Volume: 103, Issue:11 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Behavior, Animal; Cabergoline; Drug Interactions; Dyskinesia, Drug-Induced; Ergolines; Hyperkinesis; Levodopa; Macaca fascicularis; Movement; Parkinson Disease, Secondary	1996
Clinical rating of dyskinesias in Parkinson's disease: use and reliability of a new rating scale. Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:3 Topics: Antiparkinson Agents; Dystonia; Female; Humans; Hyperkinesis; Levodopa; Male; Middle Aged; Parkinson Disease; Reproducibility of Results; Severity of Illness Index; Time Factors	1999
The anticataleptic effect of 7-OH-DPAT: are dopamine D3 receptors involved? Journal of neural transmission (Vienna, Austria : 1996), 1999, Volume: 106, Issue:11-12 Topics: Animals; Antipsychotic Agents; Brain Chemistry; Catalepsy; Dextroamphetamine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Fluphenazine; Haloperidol; Hyperkinesis; Levodopa; Locomotion; Male; Naphthalenes; Pyrrolidines; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Reserpine; Tetrahydronaphthalenes	1999
Effects of lithium on dopamine D2 receptor expression in the rat brain striatum. Journal of neural transmission (Vienna, Austria : 1996), 2001, Volume: 108, Issue:3 Topics: Animals; Antidepressive Agents; Dopamine; Dopamine Agents; Dopamine Antagonists; Drug Interactions; Gene Expression Regulation; Hyperkinesis; Levodopa; Lithium Carbonate; Male; Methamphetamine; Neostriatum; Neurons; Radioligand Assay; Rats; Rats, Wistar; Receptors, Dopamine D2; RNA, Messenger; Spiperone; Transcription, Genetic; Tritium	2001
[Treatment of parkinson's syndrome. New developments]. Fortschritte der Medizin, 1978, Jun-01, Volume: 96, Issue:21 Topics: Adrenergic beta-Antagonists; Amantadine; Antidepressive Agents; Benzodiazepines; Carboxy-Lyases; Humans; Hyperkinesis; Levodopa; Parasympatholytics; Parkinson Disease; Tranquilizing Agents	1978
[Sustained levodopa efficacy in parkinsonism. Results of a four-year long-term follow-up study (author's transl)]. Der Nervenarzt, 1977, Volume: 48, Issue:4 Topics: Activities of Daily Living; Aged; Amantadine; Carboxy-Lyases; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Hyperkinesis; Levodopa; Long-Term Care; Male; Middle Aged; Motor Activity; Parasympatholytics; Parkinson Disease, Secondary; Therapeutic Equivalency; Time Factors	1977
Chronic agonist-induced hypersensitivity and on-off hyperkinesis. Annals of neurology, 1979, Volume: 6, Issue:3 Topics: Animals; Drug Hypersensitivity; Humans; Hyperkinesis; Levodopa; Parkinson Disease	1979
Methylphenidate-induced chorea: case report and pharmacologic implications. Neurology, 1978, Volume: 28, Issue:10 Topics: Animals; Attention Deficit Disorder with Hyperactivity; Brain; Child; Child, Preschool; Chorea; Dopamine; Dyskinesia, Drug-Induced; Guinea Pigs; Humans; Hyperkinesis; Levodopa; Male; Methylphenidate; Stereotyped Behavior	1978
On-off response. Clinical and biochemical correlations during oral and intravenous levodopa administration in parkinsonian patients. Neurology, 1975, Volume: 25, Issue:12 Topics: Administration, Oral; Aged; Blood Pressure; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Female; Humans; Hyperkinesis; Infusions, Parenteral; Levodopa; Long-Term Care; Male; Middle Aged; Movement Disorders; Parkinson Disease; Posture; Time Factors	1975
Improvement with L-dopa in a hyperkinetic child. Diseases of the nervous system, 1977, Volume: 38, Issue:7 Topics: Adolescent; Humans; Hyperkinesis; Levodopa; Male	1977
[Side effects in the treatment with L-dopa]. Ceskoslovenska neurologie a neurochirurgie, 1975, Volume: 38, Issue:1 Topics: Chemical and Drug Induced Liver Injury; Female; Gastrointestinal Diseases; Humans; Hyperkinesis; Levodopa; Male; Middle Aged; Parkinson Disease	1975
[Drug treatment of hyperkinesis and mental changes caused by levodopa]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1975, Jun-10, Volume: 95, Issue:16 Topics: Humans; Hyperkinesis; Levodopa; Mental Disorders; Parkinson Disease; Psychotropic Drugs	1975
Actions of dopaminergic agonists on motor function. Advances in neurology, 1975, Volume: 9 Topics: Amantadine; Animals; Apomorphine; Behavior; Dextroamphetamine; Disease Models, Animal; Dopamine Antagonists; Humans; Hyperkinesis; Levodopa; Methylphenidate; Motor Activity; Movement Disorders; Phenethylamines; Piribedil; Rats; Stereotyped Behavior; Tyrosine	1975
[Clinical aspects and course of torsion dystonia]. Klinicheskaia meditsina, 1975, Volume: 53, Issue:9 Topics: Adolescent; Adult; Aged; Female; Humans; Hyperkinesis; Levodopa; Male; Middle Aged; Muscle Tonus; Muscular Diseases; Syndrome	1975
Botulinum toxin A in orthopaedic surgery. Lancet (London, England), 1991, Sep-21, Volume: 338, Issue:8769 Topics: Botulinum Toxins; Humans; Hyperkinesis; Levodopa; Male; Middle Aged; Parkinson Disease; Rupture; Shoulder Injuries; Shoulder Joint	1991
Intraputaminal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson's disease. One-year follow-up of first clinical trial. Archives of neurology, 1991, Volume: 48, Issue:4 Topics: Adrenal Medulla; Evoked Potentials; Female; Humans; Hyperkinesis; Levodopa; Middle Aged; Nerve Growth Factors; Parkinson Disease; Psychomotor Performance; Putamen; Transplantation, Autologous	1991
[Problems of diagnosis and treatment of deforming muscular dystrophy in children]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1990, Volume: 90, Issue:8 Topics: Child; Diagnosis, Differential; Drug Therapy, Combination; Haloperidol; Hand Deformities, Acquired; Humans; Hyperkinesis; Levodopa; Muscle Hypertonia; Muscular Dystrophies; Spastic Paraplegia, Hereditary	1990
Palilalia as a symptom of levodopa induced hyperkinesia in Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 1989, Volume: 52, Issue:6 Topics: Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Echolalia; Humans; Hyperkinesis; Levodopa; Male; Parkinson Disease	1989
[Transcerebral electrophoresis of L-DOPA in the combined treatment of the hyperkinetic form of infantile cerebral palsy]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1988, Volume: 88, Issue:3 Topics: Cerebral Palsy; Child; Child, Preschool; Combined Modality Therapy; Drug Evaluation; Head; Humans; Hyperkinesis; Infant; Iontophoresis; Levodopa; Solutions	1988
[Experience with L-DOPA treatment of children with dystonia musculorum deformans and dystonic hyperkineses in infantile cerebral palsy]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1985, Volume: 85, Issue:10 Topics: Adolescent; Cerebral Palsy; Child; Child, Preschool; Dystonia; Dystonia Musculorum Deformans; Female; Humans; Hyperkinesis; Levodopa; Male	1985
[L-dopa therapy for Parkinsonism and its relationship to surgical methods of treatments]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1974, Volume: 74, Issue:5 Topics: Cardiovascular Diseases; Dyspepsia; Fear; Hallucinations; Humans; Hyperkinesis; Levodopa; Mental Disorders; Nausea; Parkinson Disease; Postoperative Care; Preoperative Care; Vomiting	1974